VeriMom¿Es salix alba extract seguro durante el embarazo?
No EU Annex II/III restriction or harmonised CLP classification was found for Salix alba extract; however the extract contains salicin which is related to salicylic acid and is a class-based concern for systemic salicylate exposure in pregnancy. Regulatory/clinical sources advise caution/avoidance in pregnancy due to salicylate content. ECHA registration lists the extract as a plant extract (not classified). PubMed genotoxicity data do not indicate reproductive teratogenicity for the extract, but clinical guidance (and lactation resources) recommend avoidance because of salicylates. (ECHA registration; PubMed; LactMed; WebMD).
Alternativas seguras a salix alba extract en el embarazo | VeriMom
Related ingredients
Frequently asked questions
- ¿Es salix alba extract seguro durante el embarazo?
- No EU Annex II/III restriction or harmonised CLP classification was found for Salix alba extract; however the extract contains salicin which is related to salicylic acid and is a class-based concern for systemic salicylate exposure in pregnancy. Regulatory/clinical sources advise caution/avoidance in pregnancy due to salicylate content. ECHA registration lists the extract as a plant extract (not classified). PubMed genotoxicity data do not indicate reproductive teratogenicity for the extract, but clinical guidance (and lactation resources) recommend avoidance because of salicylates. (ECHA registration; PubMed; LactMed; WebMD).
- ¿Es salix alba extract seguro durante la lactancia?
- LactMed and other clinical sources advise avoidance of willow bark/extract during breastfeeding because salicylates can be transferred and aspirin-like compounds have documented neonatal risks; no harmonised CLP or EU ban was found for the extract itself, but clinical precaution is recommended. Topical cosmetic use would give low but measurable exposure depending on formulation and concentration. (LactMed; WebMD; ECHA registration).
- ¿Es salix alba extract seguro para la piel del bebé?
- No specific infant dermal reproductive toxicity data were identified and no harmonised CLP or EU ban applies. Because the extract contains salicylates (which can be systemically active) there is a class-based concern (h=1) and a demonstrated metabolic pathway to salicylic acid (m=2). Dermal exposure in infants is higher relative to adults (immature barrier and higher surface-area-to-weight), so exposure score is increased by +1 for 0–3 yr skin compared with adults. Cosmetic topical use at typical low concentrations likely yields low systemic absorption but infant exposure is higher than adult. (PubMed toxicology summaries; LactMed; ECHA registration).
- ¿Cómo puntúa VeriMom a salix alba extract?
- VeriMom puntúa salix alba extract en 60/100 (riesgo medio) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a salix alba extract en el embarazo?
- Consulta nuestra lista de alternativas seguras a salix alba extract según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.